突发！北大医药董事长因“个人原因”无法履职

Group 1 - The chairman and president of Beijing University Pharmaceutical Co., Ltd., Xu Xiren, has temporarily delegated his responsibilities to other executives due to personal reasons [3] - The company's board of directors is functioning normally, and its production and operations remain stable despite the leadership changes [3] - Xu Xiren has a background in various industries, controlling 59 companies, but has limited involvement in the pharmaceutical sector [3] Group 2 - Beijing University Pharmaceutical was originally established as Southwest Synthetic Pharmaceutical Factory and was listed on the Shenzhen Stock Exchange in 1997 [4] - The company became a member of the new Fangzheng Group after China Ping An acquired Fangzheng Group through Ping An Life in 2022 [4] - A governance conflict arose in June 2023 when nearly a hundred retired employees protested due to the suspension of benefits, highlighting issues related to the recent changes in control [4]